SCHEMBL10056

SCHEMBL10056

C[C@@](F)(Oc1ccc([N+](=O)[O-])cn1)C(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.51
NPSR1 Q6W5P4 2/20 0.51
HSPB1 P04792 2/20 0.49
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
PABPC1 P11940 2/20 0.44
RAB9A P51151 6/20 0.41
GAA P10253 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
POLB P06746 1/20 0.39
CYP1A2 P05177 1/20 0.38
GABRA5 P31644 1/20 0.38
NPC1 O15118 4/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HTT P42858 1/20 0.38
CFTR P13569 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11549503 0.82 HSPB1 (0.53) MAPTNPSR1HSPB1CYP2C19KMT2A
SCHEMBL3894432 0.77 MAPT (0.51) MAPTNPSR1HSPB1CYP2C19KMT2A
SCHEMBL28723950 0.77 MAPT (0.53) MAPTNPSR1HSPB1CYP2C19KMT2A
SCHEMBL11590 0.75 MAPT (0.52) MAPTNPSR1HSPB1CYP2C19KMT2A
SCHEMBL745282 0.75 MAPT (0.52) MAPTNPSR1HSPB1CYP2C19KMT2A
SCHEMBL200375 0.75 CYP2C19 (0.54) MAPTNPSR1HSPB1CYP2C19KMT2A
SCHEMBL29974305 0.75 HSPB1 (0.56) MAPTNPSR1HSPB1CYP2C19KMT2A
SCHEMBL558792 0.75 HSPB1 (0.56) MAPTNPSR1HSPB1CYP2C19KMT2A
SCHEMBL1360440 0.75 MAPT (0.58) MAPTNPSR1HSPB1CYP2C19KMT2A
SCHEMBL9562 0.74 KDM4E (0.46) KMT2AMEN1RAB9APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed